医院抗菌谱预测肠杆菌科分离株抗菌药物耐药风险的诊断准确性:退伍军人健康管理局全国多中心评估
该研究回顾性生成2000至2019年退伍军人健康管理局127家机构的医院抗菌谱,评估其预测下一年度大肠埃希菌和克雷伯菌属分离株耐药性的诊断准确性。结果显示医院层面抗菌谱对个体患者耐药的区分能力大多较差,受体操作特征曲线下面积分别为0.686和0.715(头孢曲松)、0.637和0.675(氟喹诺酮类)、0.576和0.624(甲氧苄啶-磺胺甲噁唑)。作者认为传统医院抗菌谱在指导经验性治疗方面的效用可能较低。
要点
- 医院抗菌谱对个体患者耐药预测的区分能力大多较差,头孢曲松AUC为0.686(大肠埃希菌)和0.715(克雷伯菌属)。
- 氟喹诺酮类AUC为0.637(大肠埃希菌)和0.675(克雷伯菌属),甲氧苄啶-磺胺甲噁唑AUC为0.576和0.624。
- 抗菌谱的敏感性和特异性因抗菌药物类别和解释阈值不同而差异很大,存在明显权衡。
核心结论
- 传统医院抗菌谱对大肠埃希菌和克雷伯菌属个体患者耐药的预测性能有限,其指导经验性治疗的效用可能较低。
研究设计与样本
- 回顾性研究,基于2000至2019年全国退伍军人健康管理局127家机构的所有临床培养阳性大肠埃希菌和克雷伯菌属分离株生成医院抗菌谱。
- 采用逻辑回归模型和预定义的5步解释阈值评估抗菌谱对下一年度分离株耐药的预测准确性。
主要发现
- 大肠埃希菌分析纳入704779例患者的1484038株分离株,克雷伯菌属分析纳入340504例患者的671035株分离株。
- 医院层面抗菌谱预测个体患者耐药的受体操作特征曲线下面积:头孢曲松大肠埃希菌0.686、克雷伯菌属0.715;氟喹诺酮类大肠埃希菌0.637、克雷伯菌属0.675;甲氧苄啶-磺胺甲噁唑大肠埃希菌0.576、克雷伯菌属0.624。
- 抗菌谱的敏感性和特异性因抗菌药物类别和解释阈值不同而差异很大,存在明显权衡。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many clinical guidelines recommend that clinicians use antibiograms to inform empiric antimicrobial therapy. However, hospital antibiograms are typically generated by crude aggregation of microbiologic data, and little is known about an antibiogram's reliability in predicting antimicrobial resistance (AMR) risk at the patient-level. We aimed to assess the diagnostic accuracy of antibiograms as a tool for selecting empiric therapy for Escherichia coli and Klebsiella spp. for individual patients. METHODS: We retrospectively generated hospital antibiograms for the nationwide Veterans Health Administration (VHA) facilities from 2000 to 2019 using all clinical culture specimens positive for E. coli and Klebsiella spp., then assessed the diagnostic accuracy of an antibiogram to predict resistance for isolates in the following calendar year using logistic regression models and predefined 5-step interpretation thresholds. RESULTS: Among 127 VHA facilities, 1 484 038 isolates from 704 779 patients for E. coli and 671 035 isolates from 340 504 patients for Klebsiella spp. were available for analysis. For E. coli and Klebsiella spp., the discrimination abilities of hospital-level antibiograms in predicting individual patient AMR were mostly poor, with the areas under the receiver operating curve at 0.686 and 0.715 for ceftriaxone, 0.637 and 0.675 for fluoroquinolones, and 0.576 and 0.624 for trimethoprim-sulfamethoxazole, respectively. The sensitivity and specificity of the antibiogram varied widely by antimicrobial groups and interpretation thresholds with substantial trade-offs. CONCLUSIONS: Conventional hospital antibiograms for E. coli and Klebsiella spp. have limited performance in predicting AMR for individual patients, and their utility in guiding empiric therapy may be low.
引用
- Hasegawa S, Livorsi DJ, Perencevich EN, et al. Diagnostic Accuracy of Hospital Antibiograms in Predicting the Risk of Antimicrobial Resistance in Enterobacteriaceae Isolates: A Nationwide Multicenter Evaluation at the Veterans Health Administration. Clin Infect Dis. 2023. PMID: 37658908. doi:10.1093/cid/ciad467
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。